The combined use of alpha-methyltyrosine and threo-dihydroxyphenylserine--selective reduction of dopamine levels in the central nervous system.
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001555:Benzene Derivatives; D002247:Carbon Isotopes; D002490:Central Nervous System / Q000378:metabolism*; D004298:Dopamine / Q000096:biosynthesis / Q000378:metabolism*; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology*; D051379:Mice; D006899:Mixed Function Oxygenases / Q000037:antagonists & inhibitors; D009638:Norepinephrine / Q000096:biosynthesis / Q000378:metabolism; D012110:Reserpine / Q000494:pharmacology; D012694:Serine / Q000378:metabolism / Q000494:pharmacology*
D001555:Benzene Derivatives; D002247:Carbon Isotopes; D008781:Methyltyrosines; D012694:Serine; D012110:Reserpine; D006899:Mixed Function Oxygenases; D004298:Dopamine; D009638:Norepinephrine